## Abstract The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost‐effectiveness analysis is the incremental cost‐effectiveness ratio (ICER), which is compared with a threshol
A French approach to cost-effectiveness analysis?
✍ Scribed by Gérard de Pouvourville
- Book ID
- 106295250
- Publisher
- Springer
- Year
- 2010
- Tongue
- French
- Weight
- 104 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1618-7598
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## SUMMARY Estimates of cost‐effectiveness analyses are typically obtained either directly from ‘trial’ based analyses or indirectly via surrogate endpoints in ‘model’ based analyses. Data from clinical trials that include both surrogate and final endpoints can be used in a joint analysis that comb
Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d